-
Hanmi Pharm to sell 3 Boehringer COPD inhalers in Korea, including Spiriva and Vahelva
04 Nov 2025 08:24 GMT
Hanmi Pharmaceutical signed an agreement last … pulmonary disease (COPD) treatments nationwide: Spiriva Handihaler (inhalation capsules), Spiriva Respimat, and Vahelva … broaden treatment access and strengthen both companies’ presence in respiratory medicine.
-
Asthma Treatment Market Size Worth USD 35.93 Billion by 2034
20 Oct 2025 12:21 GMT
… drugs, stringent regulations, high manufacturing costs, and the need for clinical trials … to asthma medicines via the Pharmaceutical Benefits Scheme (PBS).
Asthma Treatment Market … asthma management with products like Spiriva Respimat, which helps improve …
-
PhRMA unveils DTC sales site, as more drugmakers join in
30 Sep 2025 14:17 GMT
… negotiate rebates on drug prices, but don … medicines and connect patients directly to available options prescribed by their doctor … Spiriva Respimat (tiotropium bromide), a once-daily, maintenance inhaler for the treatment … pay for the drug using a flexible …
-
Boehringer Ingelheim launches new direct-to-consumer platform to expand patient access to important treatments
29 Sep 2025 12:05 GMT
… SPIRIVA RESPIMAT, and call your doctor right away or seek emergency medical care. SPIRIVA … -ups (COPD exacerbations). SPIRIVA RESPIMAT is not a treatment for sudden symptoms … effects of prescription drugs to the FDA. Visit www.FDA.gov/medwatch …
-
Novartis, Boehringer DTC platforms slash prices for Cosentyx, Spiriva Respimat
29 Sep 2025 22:10 GMT
… offerings to include other drugs besides Cosentyx in the … direct-selling model for specialty medicines” to improve affordability. It … Boehringer meds—starting with its Spiriva Respimat inhalation spray for … ” order to reduce domestic drug prices, Trump set a …
-
Patients Using Popular Meds May Face a Tariff Hit: US–EU Trade Deal Targets Branded Drugs Like Ozempic and Wegovy
26 Aug 2025 00:38 GMT
… the European Union, generic pharmaceuticals and active pharmaceutical ingredients (APIs) imported … kidney conditions. It also produces Spiriva, a biologic for asthma … medications without Food and Drug Administration approval if they use ingredients from FDA …
-
Global Chronic Obstructive Pulmonary Disease Treatment Devices Market to Witness Growth at a CAGR of ~6% by 2032 | DelveInsight
05 Aug 2025 17:00 GMT
… of Spiriva® HandiHaler … FDA approval for OHTUVAYRE (ensifentrine), intended for the maintenance treatment … pipeline drug … MediciNova, Edesa Biotech, Light Chain Biosciences, Boehringer Ingelheim, Genentech, Windtree Therapeutics, Biomarck Pharmaceuticals …
-
Asthma and COPD Drugs Market to Grow at a CAGR of 7.9% and will Reach USD 73.98 billion by 2032
19 Mar 2025 17:24 GMT
… COPD Drugs Market Companies
Teva Pharmaceutical Industries Ltd … Dulera
Others
Anticholinergics
Spiriva
Others
Inhaled … the doctors have prescribed the drug.
Read … and personalized medicine are improving treatment efficacy and …
-
Ozempic, Biktarvy Among the Drugs Seeing List Price Increases at the Start of 2025
21 Jan 2025 19:02 GMT
… and Janumet XR), tiotropium bromine (Spiriva; Boehringer Ingelheim), ipratropium bromine (Atrovent … . HHS Announces Next 15 Drugs for Medicare Part D Price Negotiations. Pharmacy … /hhs-announces-next-15-drugs-for-medicare-part-d-price-negotiations
-
Chronic Obstructive Pulmonary Disease Treatment Market 2034: Clinical Trials, FDA Approvals, Companies by DelveInsight
18 Dec 2024 16:28 GMT
… Pharmaceuticals, and several others.
• Chronic Obstructive Pulmonary Disease drugs: Stiolto Respimat (Boehringer Ingelheim), Spiriva Respimat and Spiriva … Trials and FDA Approvals
Chronic … COPD) Treatment Algorithm, Current Treatment, and Medical Practices
9 …